Microbial immunosoppressant agent

Drug – bio-affecting and body treating compositions – Immune response affecting drug

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

514286, 435119, 546 63, A61K 3500

Patent

active

052526127

ABSTRACT:
Described is a new immunosuppressant, L-683,756, a bisdemethylated, ring rearranged derivative of L-683,590, produced under fermentation conditions utilizing the microorganism, Actinoplanacete sp. (Merck Culture Collection MA 6559) ATCC No. 53771. The macrolide immunosuppressant is useful in preventing human host rejection of foreign organ transplants, e.g. bone marrow and heart transplants.

REFERENCES:
New York Times (Oct. 18, 1989), pA1, by L. K. Altman.
Transplantation, vol. 32, No. 5, p. 350, by P. E. Morris.
Ann. Rev. Immunol., vol. 3, p. 415, by E. M. Sherach (1985).
J. Antiobiotics, (Nov. 1988) vol. 16 p. 1600, by Hatanaka, et al.
J. Immunology, vol. 144, pp. 251-258, No. 1, (Jan. 1, 1990).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Microbial immunosoppressant agent does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Microbial immunosoppressant agent, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Microbial immunosoppressant agent will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1904895

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.